STOCK TITAN

Kaival Brands Innvtns Grp (KAVL) Stock Price, News & Analysis

KAVL OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
143 235 sessions, November 20, 2025 to November 20, 2026
Largest daily move
+101.1% close of May 11, 2026
1-year change
-96.2% closing prices, November 20, 2025 to November 20, 2026
1-month change
-31.9% closing prices, October 16, 2026 to November 20, 2026

Company Description

Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) is a Delaware corporation based in Grant-Valkaria, Florida. According to the company’s public disclosures, Kaival Brands is focused on incubating and commercializing innovative products into mature brands, with a current emphasis on the distribution of electronic nicotine delivery systems (ENDS), also referred to as e‑cigarettes, for adults 21 years and older. The company’s common stock is listed on the Nasdaq Capital Market under the symbol KAVL.

Kaival Brands states that its business plan is to seek diversification into distributing other nicotine and non‑nicotine delivery system products, including products related to hemp‑derived cannabidiol (CBD). Through arrangements described in its news releases, Kaival Brands and Philip Morris Products S.A. (via a sublicense from Kaival Brands) are the exclusive global distributors of all products manufactured by Bidi Vapor LLC. Bidi Vapor, based in Melbourne, Florida, highlights a focus on responsible, adult‑focused marketing, age‑verification standards, and sustainability initiatives through its BIDI Cares recycling program.

The company reports that Bidi Vapor’s premier device, the BIDI Stick, is distributed exclusively by Kaival Brands. Public statements describe the BIDI Stick as a premium device made with high‑quality components and a UL‑certified battery, with technology designed to deliver a consistent vaping experience for adult smokers 21 and over. Kaival Brands identifies itself as the exclusive U.S. distributor of the BIDI Stick and certain other products manufactured by Bidi Vapor, and as a global distributor through its relationship with Philip Morris Products S.A.

Beyond distribution, Kaival Brands has disclosed efforts to broaden its platform through intellectual property and product development. Through its wholly owned subsidiary Kaival Labs, based in Grant‑Valkaria, Florida, the company reports holding a patent portfolio covering vaporizer and inhalation technologies. Company communications describe this portfolio as including existing and pending patents across areas such as extrusion dose control, product preservation, tracking and tracing usage, multiple modalities, and child safety, with patent coverage in territories including the United States, Australia, Canada, China, the European Patent Organisation, Israel, Japan, Mexico, New Zealand and South Korea. The portfolio also includes a proprietary mobile device software application used in conjunction with certain patents.

Kaival Brands has discussed pursuing third‑party licensing and development opportunities related to this inhalation technology portfolio. In its shareholder communications, the company notes that it has been exploring opportunities in markets such as cannabis, hemp/CBD, nicotine, nutraceutical and pharmaceutical applications, with the goal of generating revenue from licensing and product development activities based on these assets.

Internationally, Kaival Brands has highlighted the activities of its wholly owned subsidiary Kaival Brands International, LLC. Company disclosures state that Kaival Brands International, alongside Bidi Vapor, works with Philip Morris Products S.A. to accelerate the international distribution of ENDS products using Bidi Vapor technology, which Philip Morris Products S.A. markets under the brand name VEEV Now. These products are described as part of a broader objective of delivering a smoke‑free future to adult consumers of legal age in relevant markets.

Regulatory considerations are a significant part of Kaival Brands’ operating environment. Public updates describe how Bidi Vapor’s premarket tobacco product applications (PMTAs) for BIDI Stick devices have been under review by the U.S. Food and Drug Administration (FDA). The company has reported that the FDA issued a marketing denial order (MDO) for Bidi Vapor’s “Classic” tobacco‑flavored BIDI Stick device, while ten non‑tobacco flavored BIDI Stick products remain under FDA scientific review and, according to the company, remain available for sale through Kaival Brands subject to FDA enforcement discretion. Bidi Vapor has disclosed that it is contesting the MDO through litigation, and prior court rulings have been referenced in company communications regarding earlier FDA decisions.

Kaival Brands has also described various corporate and capital markets actions. The company announced a 1‑for‑21 reverse stock split of its common stock, effective with the opening of trading on January 25, 2024, while maintaining its Nasdaq listing under the symbol KAVL. The company has also reported public offerings of units consisting of common stock (or pre‑funded warrants) and common warrants, with stated use of proceeds for general corporate and working capital purposes and to fund ongoing operations and business expansion.

In its business updates, Kaival Brands has outlined strategic priorities that include maximizing its core ENDS distribution business, managing strategic alliances, improving operational efficiencies, and pursuing diversification through its intellectual property portfolio and potential new product lines. The company has also reported efforts to improve inventory management, refine internal data processes, and explore strategic alternatives at the parent‑company level, while indicating that Kaival Brands International, LLC is outside the scope of those strategic alternative reviews.

Corporate governance and listing status have also been addressed in Kaival Brands’ SEC filings. The company has disclosed receiving notices from Nasdaq regarding minimum bid price requirements and, in a later filing, a Nasdaq staff determination expressing the view that the company is a “public shell” based on factors such as revenue levels, asset composition, and reductions in operations. Kaival Brands has stated that it disagrees with Nasdaq’s characterization, considers itself an operating company, and intends to appeal the delisting determination. The company has also reported that it obtained an extension from Nasdaq to regain compliance with the minimum bid price rule, with potential actions such as an additional reverse stock split identified as tools to address listing requirements.

Kaival Brands has previously entered into a merger and share exchange agreement with Delta Corp Holdings Limited and a Cayman Islands holding company, which would have resulted in Kaival and Delta becoming wholly owned subsidiaries of a new public holding company. Subsequent SEC filings report that this business combination agreement was later terminated by mutual agreement under a Business Combination Termination and Release Agreement, with the parties waiving claims related to the terminated merger agreement.

Through these disclosures, Kaival Brands presents itself as a company centered on adult‑focused ENDS distribution, international licensing partnerships, and inhalation technology intellectual property, operating within a regulated environment and active in capital markets and corporate restructuring discussions.

Stock Performance

$0.0177
-11.50%
-0.0023
Last updated: at
-96.2%
Performance 1 year
$345.8K
19.5M
Shares outstanding As of September 10, 2026.

Kaival Brands Innvtns Grp (KAVL) closed at $0.0177 on November 20, 2026. Over the past 12 months, the price has lost 96.2%.

See what a $1,000 investment in KAVL would be worth today

Average down calculator for KAVL

KAVL Metrics & Rankings

Price returns through November 20, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Kaival Brands Innvtns Grp has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, offering, earnings, fda approval, stock split. View all KAVL news →

Financial Highlights

Kaival Brands Innvtns Grp generated $485K in revenue in FY2025, retaining a 100.0% gross margin, operating income reached -$16.6M, and net income was -$16.6M. Diluted earnings per share stood at -$1.51. The company generated -$2.8M in operating cash flow. The current ratio was 1.18, measuring current assets divided by current liabilities.

$485K
Revenue (FY2025)
-$16.6M
Net Income (FY2025)
-$2.8M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for KAVL.

Short Interest History

Last 12 Months

Short interest in Kaival Brands Innvtns Grp (KAVL) currently stands at 15.1 thousand shares, up 0.5% from the previous reporting period, representing 0.1% of the float. Since November 2025, short interest has decreased by 72.7%.

Days to Cover History

Last 12 Months

Days to cover for Kaival Brands Innvtns Grp (KAVL) currently stands at 2.7 days, up 173% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 143.7%. Across the settlements charted above, it has ranged from 1.0 to 2.7 days.

KAVL Company Profile & Sector Positioning

Kaival Brands Innvtns Grp (KAVL) operates in the Tobacco industry within the broader Consumer Defensive sector and is listed on the OTC.

Investors comparing KAVL often look at related companies in the same sector, including LFTD Partners Inc (LIFD), Green Leaf Innovatns Inc (GRLF), Eco-Growth Strategies Inc (ECGS), Charlies Holdings Inc (CHUC), and Cabbacis Inc (CABI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KAVL's relative position within its industry.

Frequently Asked Questions

The current stock price of Kaival Brands Innvtns Grp (KAVL) is $0.0177 as of November 20, 2026.

The market cap of Kaival Brands Innvtns Grp (KAVL) is approximately $345.8K. Learn more about what market capitalization means .

The FY2025 revenue of Kaival Brands Innvtns Grp (KAVL) is $485K, from its most recent completed fiscal year.

The FY2025 net income of Kaival Brands Innvtns Grp (KAVL) is -$16.6M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Kaival Brands Innvtns Grp (KAVL) is -$1.51 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Kaival Brands Innvtns Grp (KAVL) is -$2.8M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of Kaival Brands Innvtns Grp (KAVL) is 100.0% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Kaival Brands Innvtns Grp (KAVL), current assets divided by current liabilities, was 1.18 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Kaival Brands Innvtns Grp (KAVL) is $485K for FY2025, its most recent completed fiscal year.

The operating income of Kaival Brands Innvtns Grp (KAVL) is -$16.6M for FY2025, its most recent completed fiscal year. Learn about operating income.

According to its public disclosures, Kaival Brands Innovations Group, Inc. focuses on incubating and commercializing innovative products into mature brands, with a current emphasis on distributing electronic nicotine delivery systems (ENDS), also known as e‑cigarettes, for adults 21 years and older.

Company materials state that Kaival Brands is based in Grant‑Valkaria, Florida, and its common stock trades on the Nasdaq Capital Market under the ticker symbol KAVL.

Kaival Brands describes itself as the exclusive U.S. distributor of the BIDI Stick and certain other products manufactured by Bidi Vapor LLC. It also reports that Kaival Brands and Philip Morris Products S.A., via a sublicense from Kaival Brands, are the exclusive global distributors of all products manufactured by Bidi Vapor.

Public statements describe the BIDI Stick as Bidi Vapor’s premier electronic nicotine delivery device, distributed exclusively by Kaival Brands. It is characterized as a premium product made with high‑quality components and a UL‑certified battery, designed to deliver a consistent vaping experience for adult smokers 21 and over.

Kaival Brands has stated that its business plan is to diversify into distributing other nicotine and non‑nicotine delivery system products, including those related to hemp‑derived cannabidiol (CBD). Through its subsidiary Kaival Labs, it also reports pursuing third‑party licensing and development opportunities based on a portfolio of vaporizer and inhalation technology patents.

Kaival Labs is described as a wholly owned subsidiary of Kaival Brands focused on developing new branded and white‑label products and services in the vaporizer and inhalation technology sectors. Company disclosures state that Kaival Labs holds a portfolio of existing and pending patents covering areas such as dose control, product preservation, usage tracking, multiple modalities and child safety, along with a proprietary mobile application tied to certain patents.

Through its subsidiary Kaival Brands International, LLC, and in collaboration with Bidi Vapor and Philip Morris Products S.A., the company reports working to accelerate international distribution of ENDS products using Bidi Vapor technology. Philip Morris Products S.A. markets these products under the brand name VEEV Now in its respective markets.

Kaival Brands has reported that the U.S. Food and Drug Administration issued a marketing denial order (MDO) for Bidi Vapor’s “Classic” tobacco‑flavored BIDI Stick PMTA. The company notes that ten non‑tobacco flavored BIDI Stick products remain under FDA scientific review and, according to its statements, remain available for sale through Kaival Brands subject to FDA enforcement discretion. Bidi Vapor has disclosed that it is appealing the MDO in federal court.

Yes. The company has announced a 1‑for‑21 reverse stock split of its common stock, effective with the opening of trading on January 25, 2024, while continuing to trade on Nasdaq under the symbol KAVL. It has also reported public offerings of units composed of common stock or pre‑funded warrants and common warrants, with stated use of proceeds for general corporate and working capital purposes and to fund operations and business expansion.

Kaival Brands and Delta Corp Holdings Limited entered into a merger and share exchange agreement under which both companies would have become wholly owned subsidiaries of a Cayman Islands holding company whose shares would trade on Nasdaq. Later, an 8‑K filing reported that Kaival Brands and Delta entered into a Business Combination Termination and Release Agreement, mutually terminating the merger agreement and related ancillary agreements and waiving claims arising from those agreements.

The company has disclosed receiving Nasdaq notices regarding non‑compliance with the $1.00 minimum bid price requirement and has obtained an extension to regain compliance, with the possibility of using a reverse stock split as a remedy. In a separate notice, Nasdaq staff stated a belief that the company is a “public shell” based on factors such as revenue levels, asset composition and reduced operations. Kaival Brands has stated that it disagrees with this characterization, considers itself an operating company, and intends to appeal the delisting determination.